1. Home
  2. BLZE vs NBP Comparison

BLZE vs NBP Comparison

Compare BLZE & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$11.77

Market Cap

218.8M

Sector

Technology

ML Signal

HOLD

NBP

NovaBridge Biosciences American Depositary Shares

HOLD

Current Price

$1.77

Market Cap

225.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
NBP
Founded
2007
2014
Country
United States
United States
Employees
N/A
30
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.8M
225.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BLZE
NBP
Price
$11.77
$1.77
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$7.60
$9.00
AVG Volume (30 Days)
3.3M
695.4K
Earning Date
05-04-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
58.56
N/A
EPS
N/A
N/A
Revenue
$145,835,000.00
N/A
Revenue This Year
$10.16
N/A
Revenue Next Year
$10.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.27
N/A
52 Week Low
$3.26
$1.46
52 Week High
$18.25
$5.19

Technical Indicators

Market Signals
Indicator
BLZE
NBP
Relative Strength Index (RSI) 41.82 46.17
Support Level $3.93 $1.67
Resistance Level $18.25 $1.95
Average True Range (ATR) 1.28 0.11
MACD -0.70 -0.01
Stochastic Oscillator 0.61 17.14

Price Performance

Historical Comparison
BLZE
NBP

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About NBP NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

Share on Social Networks: